- Home
- BDSX vs ABEO Comparison
BDSX vs ABEO Comparison
Compare BDSX & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDSX
- ABEO
- Stock Information
- Founded
- BDSX 2005
- ABEO N/A
- Country
- BDSX United States
- ABEO United States
- Employees
- BDSX N/A
- ABEO N/A
- Industry
- BDSX Precision Instruments
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- BDSX Health Care
- ABEO Health Care
- Exchange
- BDSX Nasdaq
- ABEO Nasdaq
- Market Cap
- BDSX 257.0M
- ABEO 243.9M
- IPO Year
- BDSX 2020
- ABEO 1980
- Fundamental
- Price
- BDSX $1.69
- ABEO $6.46
- Analyst Decision
- BDSX Strong Buy
- ABEO Strong Buy
- Analyst Count
- BDSX 4
- ABEO 3
- Target Price
- BDSX $3.08
- ABEO $18.00
- AVG Volume (30 Days)
- BDSX 238.2K
- ABEO 245.7K
- Earning Date
- BDSX 11-05-2024
- ABEO 11-11-2024
- Dividend Yield
- BDSX N/A
- ABEO N/A
- EPS Growth
- BDSX N/A
- ABEO N/A
- EPS
- BDSX N/A
- ABEO N/A
- Revenue
- BDSX $60,902,000.00
- ABEO N/A
- Revenue This Year
- BDSX $48.06
- ABEO N/A
- Revenue Next Year
- BDSX $29.97
- ABEO $7,097.06
- P/E Ratio
- BDSX N/A
- ABEO N/A
- Revenue Growth
- BDSX 46.25
- ABEO 147.52
- 52 Week Low
- BDSX $1.15
- ABEO $3.05
- 52 Week High
- BDSX $2.21
- ABEO $9.01
- Technical
- Relative Strength Index (RSI)
- BDSX 44.40
- ABEO 67.25
- Support Level
- BDSX $1.66
- ABEO $6.06
- Resistance Level
- BDSX $1.80
- ABEO $6.48
- Average True Range (ATR)
- BDSX 0.08
- ABEO 0.33
- MACD
- BDSX -0.01
- ABEO 0.05
- Stochastic Oscillator
- BDSX 38.46
- ABEO 88.98
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.